InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding InMed Pharmaceuticals Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 7 | 9 | +2 |
| Shares | 8.47K | 303.6K | +295.1K (+3,483.9%) |
| Value | $28.5K | $665.2K | +$636.7K (+2,233.5%) |
New holders (5)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 219,998 | $481.8K | 2.50% |
| DRW Securities, LLC | 35,865 | $78.5K | 0.00% |
| Virtu Financial LLC | 20,369 | $45.0K | 0.00% |
| Renaissance Technologies LLC | 16,800 | $36.8K | 0.00% |
| Thompson Davis & Co., Inc. | 10,249 | $22.4K | 0.01% |
Sold out (3)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| UBS Group AG | 7,762 | $25.2K |
| Tower Research Capital LLC (TRC) | 400 | $1.30K |
| Bessemer Group Inc | 1 | $0 |